GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trillium Therapeutics Inc (NAS:TRIL) » Definitions » 5-Year Yield-on-Cost %

Trillium Therapeutics (Trillium Therapeutics) 5-Year Yield-on-Cost % : 0.00 (As of May. 05, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Trillium Therapeutics 5-Year Yield-on-Cost %?

Trillium Therapeutics's yield on cost for the quarter that ended in Sep. 2021 was 0.00.


The historical rank and industry rank for Trillium Therapeutics's 5-Year Yield-on-Cost % or its related term are showing as below:



TRIL's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.895
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Trillium Therapeutics's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Trillium Therapeutics's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trillium Therapeutics's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Trillium Therapeutics's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Trillium Therapeutics's 5-Year Yield-on-Cost % falls into.



Trillium Therapeutics 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Trillium Therapeutics is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Trillium Therapeutics  (NAS:TRIL) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Trillium Therapeutics 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Trillium Therapeutics's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Trillium Therapeutics (Trillium Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
100 CambridgePark Drive, Suite 510, Cambridge, MA, USA, 02140
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

Trillium Therapeutics (Trillium Therapeutics) Headlines

From GuruFocus

Trillium Securityholders Approve Acquisition by Pfizer

By Marketwired Marketwired 10-26-2021